Atlas Trials

A Study to Evaluate the Immunogenicity and Safety of a Recombinant Respiratory Syncytial Virus Vaccine in Older Adults Aged 60 Years and Older

Clinical trial NCT07208461 · ACTIVE_NOT_RECRUITING

Trial details

NCT number
NCT07208461
Sponsor
Guangzhou Patronus Biotech Co., Ltd.
Status
ACTIVE_NOT_RECRUITING
Phase
Phase 2
Study type
INTERVENTIONAL
Respiratory Syncytial Virus Infection Prevention
Start date
2025-10-21
Primary completion
2026-03-01
Enrollment
700

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.